Market Business Insights Contraceptive Market
Request Sample Buy Now

Market Outline

The global contraceptive market is projected to grow significantly over the next decade, with a compound annual growth rate (CAGR) of 5%. The market is expected to generate a revenue of $100 billion USD in 2022, which is anticipated to grow to $150 billion USD by 2030. This growth can be attributed to several factors, including increasing awareness about the benefits of using contraceptives, rising disposable incomes in developing countries, and government initiatives to promote family planning.

The market is segmented into four major categories: oral contraceptives, injectables, intrauterine devices, and condoms. Oral contraceptives account for the largest share of the market, with a share of 40%. Within this category, combined oral contraceptives and progestogen-only pills are major sub-segments. Injectable contraceptives have a share of 20%, with Depo-Provera and Implanon being the major sub-segments. Intrauterine devices (IUDs) account for 15% of the market, with Levonorgestrel and Copper IUDs being the major sub-segments. Condoms, which have a share of 25%, are the fourth major category.

The market is dominated by three major companies: Pfizer, Merck, and Bayer. North America is the largest region for the contraceptive market, while the Asia Pacific region is expected to witness the fastest growth in the coming years. However, the market faces several challenges, including religious and cultural taboos, side effects of some contraceptives, and lack of access to contraceptives in some parts of the world.

Looking ahead, there are several opportunities for growth in the contraceptive market, including the development of new and improved contraceptives, expanding the market in developing countries, and targeting new segments of the population such as teenagers and men. Overall, the global contraceptive market is poised for steady growth in the coming years, driven by changing demographics and increased awareness of the importance of family planning.

Market Key Points

1. The global contraceptive market is estimated to reach 100 billion USD Million in revenue by 2022 and 150 billion USD Million by 2030, with a CAGR of 5%.

2. Oral contraceptives account for the largest segment of the market, with a 40% share, followed by condoms (25%), injectables (20%), and intrauterine devices (15%).

3. Pfizer, Merck, and Bayer are the major companies operating in the contraceptive market.

4. North America is currently the largest market for contraceptives, while Asia Pacific is expected to be the fastest-growing region.

Report Snapshot

Base Year 2021
Forecast Year 2022 - 2030
Revenue 2022 100 billion USD
Revenue 2030 150 billion USD
CAGR 5%
Fastest Growing Region North America
Largest Region Asia Pacific

5. Increasing awareness about the benefits of using contraceptives, rising disposable incomes in developing countries, and government initiatives to promote family planning are the major drivers of the market.

6. Religious and cultural taboos, side effects of some contraceptives, and lack of access to contraceptives in some parts of the world are the main restraints.

7. Development of new and improved contraceptives, expanding the market in developing countries, and targeting new segments of the population are the key opportunities for growth in the market.

Market Dynamics (DRO)

Drivers refer to the factors that are positively impacting the growth of the contraceptive market. In this case, the drivers include increasing awareness about the benefits of using contraceptives, rising disposable incomes in developing countries, and government initiatives to promote family planning. These drivers are leading to an increase in demand for contraceptives, which is expected to result in growth in the market revenue.

Restraints refer to the factors that can potentially limit the growth of the contraceptive market. In this case, the restraints include religious and cultural taboos, side effects of some contraceptives, and lack of access to contraceptives in some parts of the world. These restraints can have a negative impact on the adoption of contraceptives and thereby limit the growth of the market.

Opportunities refer to the areas where potential for growth and innovation exist for the contraceptive market. In this case, the opportunities include the development of new and improved contraceptives, expanding the market in developing countries, and targeting new segments of the population. These opportunities can be leveraged to tap new markets and improve the market share and revenue of the contraceptive companies.

Contraceptive Market Segment Insights

1) Oral Contraceptives - This segment accounts for 40% of the total contraceptive market. It has two subsegments - Combined Oral Contraceptives and Progestogen-Only Pills. Some of the key points regarding this segment are:

- Combined Oral Contraceptives contain both estrogen and progesterone hormones, while Progestogen-Only Pills contain only progesterone. Both are effective in preventing unwanted pregnancies.

- These pills are available in various formulations, including daily pills, weekly pills, and monthly pills.

- There are different types of formulations available in the market for the convenience and comfort of women.

- This segment is expected to witness growth due to the increasing demand for hormonal contraceptives.

2) Injectables - This segment accounts for 20% of the total contraceptive market. It has two subsegments - Depo-Provera and Implanon.

- Depo-Provera is an injection form of contraceptive that contains a synthetic hormone known as medroxyprogesterone acetate. It provides protection against pregnancy for up to 3 months.

- Implanon is a small, flexible rod that is inserted under the skin. It releases a hormone that prevents ovulation, providing protection against pregnancy for up to 3 years.

- This segment is witnessing growth due to the increasing demand for long-acting contraceptives.

3) Intrauterine Devices (IUDs) - This segment accounts for 15% of the total contraceptive market. It has two subsegments - Levonorgestrel IUD and Copper IUD.

- Levonorgestrel IUD is a small, T-shaped device that is inserted into the uterus. It releases a hormone that prevents ovulation and thickens the cervical mucus to prevent sperm from reaching the egg.

- Copper IUD is a small, T-shaped device that is inserted into the uterus. It works by preventing sperm from fertilizing the egg.

- This segment is witnessing growth due to factors such as high efficacy rates and longer protection periods.

4) Condoms - This segment accounts for 25% of the total contraceptive market. It is the only contraceptive method that also provides protection against sexually transmitted infections (STIs). Some key points regarding this segment are:

- Condoms are available in both male and female versions.

- Male condoms are made of latex, polyurethane or polyisoprene. They work by preventing sperm from entering the vagina.

- Female condoms are made of polyurethane. They work by providing a physical barrier to prevent sperm from entering the vagina.

- This segment is witnessing growth due to the increasing awareness about STIs and the importance of safe sex practices.

Overall, the contraceptive market is witnessing some major developments in product innovation, the introduction of digital technologies, and strategic partnerships. This is expected to drive market growth in the coming years.

Regional Insights

According to the given data, the largest region for the contraceptive market is North America, while the fastest-growing region is Asia Pacific. This indicates a significant opportunity for companies operating in the contraceptive market to focus on expanding their presence in Asia Pacific. The rising disposable incomes in developing countries in Asia Pacific, coupled with increasing awareness about the benefits of using contraceptives, and government initiatives to promote family planning are some of the key drivers for the growth of the market in this region. However, the market is also affected by restrains such as religious and cultural taboos, side effects of some contraceptives, and lack of access to contraceptives in some parts of the world. Therefore, companies need to develop strategic plans to address these challenges and capitalize on the growth opportunities in developing regions.

Key Market Trends

Recent market trends in the contraceptive industry include the development of new forms and methods of contraception, such as long-acting reversible contraceptives (LARCs) and digital health tools to aid in contraceptive use. There is also an increasing focus on providing access to contraceptives in low-income and underserved communities through government initiatives and partnerships with nonprofit organizations. Additionally, there is growing interest in expanding the market for male contraceptives, which is currently limited to condoms and vasectomy. Finally, there is a shift towards more personalized and tailored approaches to contraceptive care, with an emphasis on patient preferences and individualized decision-making.

Key Companies Insight

The contraceptive market is a highly competitive market with well-established players such as Pfizer, Merck, and Bayer. These companies have a strong presence globally and offer a wide range of contraceptive products. Oral contraceptives hold the largest market share with combined oral contraceptives and progestogen-only pills being the major sub-segments. The market for injectables and IUDs is also growing due to their advantages over oral contraceptives. The demand for condoms is also significant, especially in developing countries.

North America is the largest market for contraceptives, but the Asia Pacific region is expected to grow the fastest due to rising awareness among the population and government initiatives in developing countries. The key drivers of growth in the contraceptive market include increasing awareness about the benefits of contraceptives, rising disposable incomes in developing countries, and government initiatives to promote family planning. However, religious and cultural taboos, side effects of some contraceptives, and lack of access to contraceptives in some parts of the world are major restraints.

To capitalize on the opportunities in the market, companies can focus on developing new and improved contraceptives to meet the changing needs of consumers and expanding the market in developing countries by increasing accessibility and affordability of their products. They can also target new segments of the population by offering customized products for different age groups, income levels, and gender. Overall, the contraceptive market is expected to grow at a CAGR of 5% from 2022 to 2030, providing ample opportunities for existing and new players in the market.

Recent Developments

The global contraceptive market has witnessed significant growth in recent years due to increasing awareness about the benefits of using contraceptives, rising disposable incomes in developing countries, and government initiatives to promote family planning. The market is expected to continue its growth trajectory over the forecast period, with a projected CAGR of 5%.

One of the major segments in the contraceptive market is the oral contraceptives segment, which holds a significant share of around 40%. It comprises sub-segments such as combined oral contraceptives and progestogen-only pills. The injectables segment holds a share of around 20%, with sub-segments such as Depo-Provera and Implanon. The intrauterine devices (IUDs) segment holds a share of around 15% and comprises sub-segments such as Levonorgestrel IUD and Copper IUD. The condoms segment holds a share of around 25%, and as a mass-market product, does not have any identifiable sub-segments.

The market is dominated by major players such as Pfizer, Merck, and Bayer. These companies are investing heavily in research and development to come up with new and improved contraceptives as well as expanding their market presence in developing countries. The contraceptives market is highly competitive, with players competing on the basis of technology, price, and distribution.

North America is the largest market for contraceptives, accounting for a significant share of the global market. However, Asia Pacific is the fastest-growing market, driven by increasing awareness about family planning and rising disposable incomes in countries such as India and China.

The market, however, faces several challenges, with some religious and cultural taboos around using contraceptives, as well as side-effects of some contraceptives. Additionally, there is a lack of access to contraceptives in some parts of the world, which hampers the growth of the market. Expanding the market in developing countries and targeting new segments of the population offer significant opportunities for players in the market.

In conclusion, the global contraceptive market is growing steadily, with major players investing in research and development to come up with new and improved contraceptives. The market is highly competitive, with players competing on the basis of technology, price, and distribution. The Asia Pacific region offers significant growth opportunities, while challenges such as cultural taboos and lack of access to contraceptives must be addressed.

Report Coverage

Companies Covered
  • Pfizer
  • Merck
  • Bayer

Above list is not exhaustive, you can add required companies.
Segments Covered
  • Oral Contraceptives
    • Combined Oral Contraceptives
    • Progestogen-Only Pills
  • Injectables
    • Depo-Provera
    • Implanon
  • Intrauterine Devices (IUDs)
    • Levonorgestrel IUD
    • Copper IUD

Segment can be customized. You can ask for customization.
Purchase Option Avail of customized purchase options to meet your exact research needs. Explore purchase options

Contraceptive Report FAQ

The Contraceptive market is expected to be worth USD XX billion in 2022, rising at a CAGR of XX percent to USD XX billion by 2030.
Globally established firms such as dominate the Contraceptive market. To gain traction in this increasing Contraceptive industry, these organisations focus on producing new goods, implementing expansion plans, and engaging in collaboration...
Contraceptive Market production remained significantly disrupted by the COVID-19 pandemic. The global production of Contraceptive pre-COVID was expected to grow from XX million units in 2020 to XX million units by 2025, with the major markets in the applicat...
When the lockdown Contraceptive market is released, the market will make up for the losses it has sustained by 2024.
During the projection period, the worldwide Contraceptive market is expected to see a significant growth in demand for residential applications.
The global Contraceptive market is divided into three categories: type, application, and region.

We Accept
Select License
Includes
  • Purchase Report Sections
  • Regional analysis
  • Segmentation analysis
  • Industry outlook
  • Competitive landscape
Latest Reports